术后延迟血解:任何可能出错的东西都会出错-墨菲定律
Beliza Chemutai1, Muhammed Omar Ali1, Jaimin Vinod Varsani2
1Department of Internal Medicine Gulu Regional Referral Hospital Gulu Uganda.
Clinical case reports
|December 30, 2024
概括
静脉注射阿尔特苏纳酸治疗后的后疟疾性贫血可能表明延迟的血液溶解. 密切监测对于治疗严重疟疾的患者至关重要,无论他们的病史或位置如何.
科学领域:
- 传染性疾病 传染性疾病
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的疟疾是一种危及生命的疾病,通常用静脉注射阿尔特苏纳酸治疗.
- 疟疾后贫血是疟疾治疗后的一个已知的并发症.
- 延迟血液溶解是某些抗疟疾药物的罕见但严重的副作用.
研究的目的:
- 为了突出考虑在患有后疟疾性贫血的患者中使用阿尔特苏纳特后延迟血解的重要性.
- 强调需要对因严重疟疾而接受静脉注射阿特苏纳酸治疗的患者进行警监测.
主要方法:
- 这是一个临床观察和差异诊断讨论.
- 患者病例和相关文献的综述关于阿尔特苏纳酸治疗和血液溶解.
主要成果:
- 疟疾后贫血可能是静脉注射阿尔特苏纳特后延迟血液溶解的预示标志.
- 这种并发症甚至可以发生在以前没有接触过疟疾的患者或在非流行地区的患者中.
结论:
- 马拉里后延迟血液溶解是疟疾后贫血患者的关键差异诊断.
- 对于所有因严重疟疾而接受静脉注射阿尔特苏纳酸治疗的患者来说,延迟血液溶解的持续监测至关重要.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
Drug toxicity: Idiosyncratic Reactions
220
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
220
Pharmaceutical Poisoning: Potential Scenarios
116
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
2.1K
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
2.1K
Hemorrhagic Stroke ll: Pathophysiology
30
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
30
Hepatic Encephalopathy
53
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53


